Compare ALX & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALX | AZTA |
|---|---|---|
| Founded | 1928 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Machinery/Components |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 1994 | 1996 |
| Metric | ALX | AZTA |
|---|---|---|
| Price | $243.83 | $34.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $35.25 |
| AVG Volume (30 Days) | 21.3K | ★ 641.1K |
| Earning Date | 11-02-2026 | 11-20-2026 |
| Dividend Yield | ★ 7.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 31.15 | N/A |
| Revenue | $213,183,000.00 | ★ $593,821,000.00 |
| Revenue This Year | $14.78 | $3.59 |
| Revenue Next Year | N/A | $4.26 |
| P/E Ratio | $7.93 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $201.28 | $15.93 |
| 52 Week High | $289.43 | $41.73 |
| Indicator | ALX | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 30.44 | 62.75 |
| Support Level | $234.50 | $32.40 |
| Resistance Level | $251.04 | $37.49 |
| Average True Range (ATR) | 4.38 | 1.08 |
| MACD | 0.02 | 0.12 |
| Stochastic Oscillator | 0.00 | 88.33 |
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing, and redeveloping its properties. It has five properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City, which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.